A Strategy for Collecting Pharmacoeconomic Data During Phase II/III Clinical Trials
- 1 March 1996
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 9 (3) , 264-277
- https://doi.org/10.2165/00019053-199609030-00007
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- The Analysis of Censored Treatment Cost Data in Economic EvaluationMedical Care, 1995
- Economic Analysis of Health Care Technology: A Report on PrinciplesAnnals of Internal Medicine, 1995
- The Journal's Policy on Cost-Effectiveness AnalysesNew England Journal of Medicine, 1994
- Statistical analysis of cost outcomes in a randomized controlled clinical trialHealth Economics, 1994
- Valuation of medical resource units collected in health economic studies.1994
- In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health CareMedical Care, 1994
- Methods for assessing relative importance in preference based outcome measuresQuality of Life Research, 1993
- Economic evaluation and quality of life assessments in cancer clinical trials: The CHART trialEuropean Journal Of Cancer, 1993
- The integration of health quality of life in clinical research: experiences from cardiovascular clinical trials.1992
- The Distinction Between Cost and ChargesAnnals of Internal Medicine, 1982